| A review on anticancer potential of bioactive heterocycle quinoline O Afzal, S Kumar, MR Haider, MR Ali, R Kumar, M Jaggi, S Bawa European Journal of Medicinal Chemistry 97, 871-910, 2015 | 749 | 2015 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 484* | 2021 |
| Optimizing drug delivery systems using systematic" design of experiments." Part I: fundamental aspects B Singh, R Kumar, N Ahuja Critical Reviews™ in Therapeutic Drug Carrier Systems 22 (1), 2005 | 466 | 2005 |
| Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer V Noronha, VM Patil, A Joshi, N Menon, A Chougule, A Mahajan, A Janu, ... Journal of Clinical Oncology 38 (2), 124-136, 2020 | 368 | 2020 |
| Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review R Kumar, OP Katare Aaps Pharmscitech 6, E298-E310, 2005 | 339 | 2005 |
| Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation A Bhatia, R Kumar, OP Katare J Pharm Pharm Sci 7 (2), 252-259, 2004 | 225 | 2004 |
| Biological activities of pyrazoline derivatives-A recent development S Kumar, S Bawa, S Drabu, R Kumar, H Gupta Recent patents on anti-infective drug discovery 4 (3), 154-163, 2009 | 208 | 2009 |
| Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for … TW Robbins, J Semple, R Kumar, MI Truman, J Shorter, A Ferraro, B Fox, ... Psychopharmacology 134, 95-106, 1997 | 168 | 1997 |
| Compiler and method for automatically building version compatible object applications AW Carter, R Kumar, AR Solomon US Patent 6,519,767, 2003 | 155 | 2003 |
| Structural modifications of quinoline-based antimalarial agents: Recent developments S Bawa, S Kumar, S Drabu, R Kumar Journal of Pharmacy and Bioallied Sciences 2 (2), 64-71, 2010 | 150 | 2010 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial E Abaleke, M Abbas, S Abbasi, A Abbott, A Abdelaziz, S Abdelbadiee, ... The Lancet 397 (10274), 605-612, 2021 | 121 | 2021 |
| Approaches towards the synthesis of 5-aminopyrazoles R Aggarwal, V Kumar, R Kumar, SP Singh Beilstein journal of organic chemistry 7 (1), 179-197, 2011 | 112 | 2011 |
| Antidepressant potential of nitrogen-containing heterocyclic moieties: an updated review N Siddiqui, S Bawa, R Ali, O Afzal, MJ Akhtar, B Azad, R Kumar Journal of Pharmacy and Bioallied Sciences 3 (2), 194-212, 2011 | 104 | 2011 |
| Emerging antibiotic resistance in Pseudomonas-A challenge D Arora, N Jindal, R Kumar, M Romit Int J Pharm Pharm Sci 3 (2), 82-4, 2011 | 102 | 2011 |
| Design, development and optimization of nimesulide-loaded liposomal systems for topical application B Singh, G Mehta, R Kumar, A Bhatia, N Ahuja, OP Katare Current drug delivery 2 (2), 143-153, 2005 | 95 | 2005 |
| Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation R Kumar, B Singh, G Bakshi, OP Katare Pharmaceutical development and technology 12 (6), 591-601, 2007 | 94 | 2007 |
| Pseudomonas aeruginosa inducing rice resistance againstRhizoctonia solani: Production of salicylic acid and peroxidases R Saikia, R Kumar, DK Arora, DK Gogoi, P Azad Folia Microbiologica 51, 375-380, 2006 | 93 | 2006 |
| Module dependency based incremental compiler and method IG Caron, AW Carter, DM Canady, T Corbett, R Kumar US Patent 5,586,328, 1996 | 92 | 1996 |
| The neutrophil–lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials R Kumar, E Geuna, V Michalarea, M Guardascione, U Naumann, ... British journal of cancer 112 (7), 1157-1165, 2015 | 91 | 2015 |
| A study of the continuous casting mold using a pareto-converging genetic algorithm N Chakraborti, R Kumar, D Jain Applied Mathematical Modelling 25 (4), 287-297, 2001 | 85 | 2001 |
Kumar PrabhashProf, Medical Oncology, Tata Memorial Hospital在 tmc.gov.in 的电子邮件经过验证
